Evidence map›Paper›PMID 39920710›Full record

Trial reportCritical care (London, England)2025

Liberal versus restrictive transfusion strategies in subarachnoid hemorrhage: a secondary analysis of the TRAIN study.

Chahnez Taleb, Elisa Gouvea Bogossian, Carla Bittencour Rynkowski, Kirsten Møller, Piet Lormans, Manuel Quintana Diaz, Anselmo Caricato, Luigi Zattera, Pedro Kurtz, Geert Meyfroidt and 17 more

Registry-linked trialAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Critical care (London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02968654 (Transfusion Strategies in Acute Brain Injured Patients. A Prospective Multicenter Randomized Study.), which is not on this map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02968654 nacompletednot on this map

Transfusion Strategies in Acute Brain Injured Patients. A Prospective Multicenter Randomized Study.

TypeinterventionalSponsorErasme University HospitalRan2016 to 2023Enrolled850ConditionsAcute Brain Injury, Blood TransfusionArmsRestrictive Transfusion Strategy, Liberal Transfusion Strategy
3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors.

Chahnez Taleb *Department of Intensive Care, Erasme Hospital, Université libre de Bruxelles, Brussels, Belgium.
Elisa Gouvea Bogossian *Department of Intensive Care, Erasme Hospital, Université libre de Bruxelles, Brussels, Belgium. elisa.gouvea.bogossian@ulb.be.
Carla Bittencour RynkowskiIntensive Care Unit of Cristo Redentor Hospital, Porto Alegre, Brazil.
Kirsten MøllerDepartment of Neuroanaesthesiology, Rigshospitalet - University of Copenhagen, Copenhagen, Denmark.
Piet LormansDepartment of Intensive Care, AZ Delta, Roeselaere, Belgium.
Manuel Quintana DiazDepartment of Intensive Care Medicine, Hospital Universitario de La Paz, Madrid, Spain.
Anselmo CaricatoInstitute of Anesthesiology and Intensive Care, Catholic University School of Medicine, Rome, Italy.
Luigi ZatteraDepartment of Anesthesiology and Intensive Care, Hospital Clínic de Barcelona, University of Barcelona, Barcelona, Spain.
Pedro KurtzDepartment of Intensive Care Medicine, DOr Institute of Research and Education, Rio de Janeiro, Brazil.
Geert MeyfroidtDepartment and Laboratory of Intensive Care Medicine, University Hospitals Leuven and KU Leuven, Leuven, Belgium.
Herve QuintardDivision of Intensive Care Medicine, Department of Anesthesiology, Clinical Pharmacology, Intensive Care, and Emergency Medicine, Geneva University Hospital, Geneva, Switzerland.
Maria Celeste DiasNeurocritical Care Unit, Medical University Center (CUME), Porto, Portugal.
Angelo GiacomucciAnestesia and Intensive Care, Azienda Ospedaliera di Perugia, Perugia, Italy.
Charlotte CastelainDepartment of Anesthesia and Intensive Care Medicine, AZ Groeninge, Kortrijk, Belgium.
Russell ChabanneNeurocritical Care Unit, Neurosurgical and Neurointerventional Anesthesiology Clinic, Division of Anesthesiology, Critical Care and Peri-Operative Medicine, University Hospital of Clermont-Ferrand, Clermont-Ferrand, France.
Pilar Marcos-NeiraDepartment of Intensive Care Medicine, Hospital Universitari Germans Trias i Pujol, Barcelona, Spain.
Stepani BendelDepartment of Intensive Care, Kuopio University Hospital, Kuopio, Finland.
Ahmed Subhy AlsheikhlyHamad Medical Corporation / Weill Cornell Medicine - Qatar, Doha, Qatar.
Mohamed ElbahnasawyTanta University Hospital, Tanta, El Gharbeya, Egypt.
Samuel GayIntensive Care Unit, Centre Hospitalier Annecy-Genevois, Epagny Metz-Tessy, France.
Maximilian D'OnofrioArtemidis Zatti Hospital, Viedma, Rio Negro, Argentina.
Konstantin A PopugaevDepartment of Intensive Care, Sklifosovsky Research Institute of Emergency Medicine of the Moscow Healthcare Department, Moscow, Russia.
Nikolaos MarkouGeneral Hospital of Eleusis Thriasion, Magoula, Greece.
Pierre BouzatInserm, U1216, CHU Grenoble Alpes, Grenoble Institut Neurosciences, Université Grenoble Alpes, Grenoble, France.
Jean-Louis VincentDepartment of Intensive Care, Erasme Hospital, Université libre de Bruxelles, Brussels, Belgium.
Fabio Silvio TacconeDepartment of Intensive Care, Erasme Hospital, Université libre de Bruxelles, Brussels, Belgium.
TRAIN Study Trial Group

Funding

European Society of Intensive Care NeXT Grant
6 · The paper itself

Abstract

backgroundThe optimal hemoglobin (Hb) threshold to trigger red blood cell transfusions (RBCT) in subarachnoid hemorrhage (SAH) patients is unclear. This study evaluated the impact of liberal versus restrictive transfusion strategies on neurological outcome in patients with SAH.

methodsThis is a pre-planned secondary analysis of the "TRansfusion Strategies in Acute brain INjured Patients" (TRAIN) study. We included all SAH patients from the original study that were randomized to receive RBCT when Hb levels dropped below 9 g/dL (liberal group) or 7 g/dL (restrictive group). The primary outcome was an unfavorable neurological outcome at 180 days, defined by a Glasgow Outcome Scale Extended score of 1-5.

resultsOf the 190 SAH patients in the trial, 188 (98.9%) had data available for the primary outcome, with 86 (45.3%) in the liberal group and 102 (53.6%) in the restrictive group. Patients in the liberal group were older than in the restrictive group, but otherwise had similar baseline characteristics. Patients in the liberal group received more RBCT and showed higher Hb levels over time. At 180 days, 57 (66.3%) patients in the liberal group and 78 (76.4%) in the restrictive group had unfavorable outcomes (risk ratio, RR 0.87; 95% confidence intervals, 95% CI 0.71-1.04). Patients in the liberal group had a significantly lower risk of cerebral ischemia (RR 0.63; 95% CI 0.41-0.97). In a multivariate analysis, randomization to the liberal group was associated with a lower risk of unfavorable outcome (RR 0.83, 95% CI 0.70-0.99).

conclusionsA liberal transfusion strategy was not associated with a lower incidence of unfavorable outcome after SAH when compared to a restrictive strategy. However, in a multivariable analysis adjusted for confounders randomization to the liberal group was associated with lower risk of unfavorable outcome. The occurrence of cerebral ischemia was significantly lower in the liberal transfusion strategy group.

trial registrationClinicalTrials.gov number-NCT02968654 registered on November 16th, 2016.

Indexed as

Blood TransfusionErythrocyte TransfusionSubarachnoid HemorrhageAgedFemaleGlasgow Outcome ScaleHemoglobinsHumansMaleMiddle AgedTreatment OutcomeHemoglobinsAcute brain injuryAnemiaBloodStroke

Identifiers

PMID39920710
PMCPMC11803982

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.